ANATOMIC PATHOLOGY
Antimony concentrations
in nodal tissue can confirm sentinel node identity
Scolyer RA, Thompson JF, Li LX,
Beavis A, et. al.
The sentinel node biopsy procedure is a highly accurate method of staging
patients with cutaneous melanoma and the tumor-harboring
status of sentinel nodes is the most important prognostic factor. For
the procedure to provide accurate prognostic information, however, it
is essential that 'true' sentinel nodes are removed and examined thoroughly.
A technique to confirm sentinel node identity may reduce the false-negative
rate of the procedure. The authors have found that antimony (originating
from the antimony sulfide colloid used for preoperative lymphoscintigraphy
in authorsinstitution)
can be measured in tissue sections of sentinel nodes using inductively
coupled plasma mass spectrometry. The aims of this study were to determine
whether antimony concentrations can be used to confirm that removed
sentinel nodes are 'true' sentinel nodes and to differentiate sentinel
nodes from nonsentinel nodes. In all, 24 patients who had both a tumor-positive
sentinel node and a tumor-negative nonsentinel
node removed from one regional node field during the same operation,
were identified. Tissue sections (50 microm)
thick were cut from archival paraffin blocks of each of the sentinel
nodes and nonsentinel nodes. Antimony concentrations in the tissue sections
were measured using inductively coupled plasma mass spectrometry. The
median and mean concentrations of antimony in parts per billion were
0.526 and 1.198, respectively (range 0.020-7.596) in the sentinel nodes,
and 0.043 and 0.123 (range 0-0.800) in the nonsentinel
nodes (P=0.004). In four of the 24 pairs, both the presumed sentinel
nodes and the nonsentinel nodes had very low antimony levels (less than
0.18 parts per billion), suggesting that nodes designated as sentinel
nodes may not have been 'true' sentinel nodes. It is concluded that
determination of antimony concentrations within sentinel nodes using
the highly sensitive method of inductively coupled plasma mass spectrometry
can confirm the identity of sentinel nodes and validate the sentinel
node technique.
Mod
Pathol. 2004 Oct; 17(10): 1191-7.
Frozen section
diagnosis for axillary sentinel lymph nodes: the
first six years
Mitchell ML.
Intraoperative
frozen section of axillary lymph nodes for
the detection of metastatic breast cancer
has been controversial because of the labor-intensive techniques necessary
to obtain a highly sensitive test, and because of the uncertain significance
of frequently detected submicrometastatic
carcinoma. In total, 874 consecutive axillary
sentinel lymph node cases examined by intraoperative
frozen section over a 6-year period were reviewed retrospectively. Frozen
section had a sensitivity of 60% and was 100% specific, but when cases
with submicrometastatic tumor cells were considered negative, the
sensitivity rose to 83%. Rare cases were called 'atypical' on frozen
section; almost all of these cases were negative for carcinoma on permanent
sections.
Mod Pathol.
2004 Sep 10
Pathological
work-up of sentinel lymph nodes in breast cancer.
Review of current data to be considered for the formulation of guidelines
Cserni
G, Amendoeira I, Apostolikas
N, Bellocq JP
Controversies and inconsistencies regarding the pathological work-up of
sentinel lymph nodes (SNs) led the European Working
Group for Breast Screening Pathology (EWGBSP) to review published data and
current evidence that can promote the formulation of European guidelines for
the pathological work-up of SNs. After an evaluation
of the accuracy of SN biopsy as a staging procedure, the yields of different
sectioning methods and the immunohistochemical
detection of metastatic cells are reviewed. Currently
published data do not allow the significance of micrometastases
or isolated tumour cells to be established, but it is
suggested that approximately 18% of the cases may be associated with further
nodal (non-SN) metastases, i.e. approximately 2% of all patients initially
staged by SN biopsy. The methods for the intraoperative
and molecular assessment of SNs are also surveyed.
Eur J Cancer. 2003 Aug; 39(12): 1654-67.
Cervical Lymphadenopathy,
Fever and Leukopenia (Histiocytic-Necrotizing
Lymphadenitis or Kikuchi Disease)
Kikuchi,
Masahiro MD; Ohshima, Koichi MD
Kikuchi disease or histiocytic necrotizing
lymphadenitis is associated with the following characteristic clinical
features: appearance in adolescence, a preference to females, cervical
lymphadenopathy, leukopenia with
a few atypical lymphocytes, fever over 38[degrees]C,
skin rashes, spontaneous regression within several months and rare recurrence.
Histopathologically, the disease demonstrates distinctive
features, such as a focal, partial, or diffuse involvement of the neck
lymph nodes with accumulation of transformed lymphocytes, immunoblasts,
plasmacytoid dendritic
cells, histiocytes, either with or without
phagocytosis, and the presence of apoptotic cells in the paracortex or cortex. The absence of neutrophils,
eosinophils, and plasma cells in the affected
foci is noticeable. Necrotic changes and appearance of foamy histiocytes
are occasionally seen in these lymph nodes. The cells in the affected
areas consist of CD8-positive cells with high proliferation activity
and apoptotic changes, CD4- and MPO-positive cells and histiocytes,
indicating a general enhancement of apoptotic activity. Similar histopathological changes are noticed in other organs, such
as the skin and bone marrow. These findings indicate that Kikuchi disease
is not a disease of the lymph node but rather a generalized disease.
The activated apoptotic activity and proliferation of lymphoid cells
in affected foci suggest a viral origin of the disease, although this
has not been confirmed yet.
Pathology
Case Reviews. 9(5): 199-205, September/October 2004.
One Patient, Two
Lymphomas
Simultaneous Primary Gastric Marginal Zone Lymphoma and
Primary Duodenal Follicular Lymphoma
Zuoqin
Tang, MD, Wen Jing, MD, Neal Lindeman, MD
Authors
report the case of a 73-year-old man who presented with a 2- to 3-month history
of epigastric discomfort and guaiac-positive
stool. An upper gastrointestinal endoscopy revealed a
diffuse erythematous nodular mucosa and submucosal thickening in the stomach. Diffuse mucosal nodularity was also found in the second portion of the
duodenum. A complete workup with histologic, immunohistochemical, and molecular studies revealed 2
distinct, apparently unrelated lymphomas, namely, a gastric marginal zone
B-cell lymphoma (mucosa-associated lymphoid tissue type) in a background of Helicobacter
pylori gastritis and a grade 1/3 duodenal follicular lymphoma. The
patient was then treated with an H pylori eradication regimen. No
therapy was given for his duodenal follicular lymphoma because his symptoms were
thought to be due to the gastric disease and because the duodenal lesion was
small. A 6-month follow-up with upper gastrointestinal endoscopy
revealed only focal biopsy scarring in the stomach and an apparently normal
duodenum. The follow-up biopsies revealed significant regression of his
mucosa-associated lymphoid tissue lymphoma, but persistence of his duodenal
follicular lymphoma. The combination of these 2 lymphomas in the same patient
and the different clinical responses to antibiotic treatment make this case
unique.
Archives of Pathology and Laboratory Medicine: Vol. 128, No. 9,
pp. 10351038.
OCT4: A Novel Biomarker for Dysgerminoma of the Ovary
Cheng, Liang MD,
Thomas, Antoinette MD
The prognosis and therapy for dysgerminomas are different from those of other ovarian tumor
types, making accurate diagnosis imperative for patient care. OCT4 (POU5F1)
is a transcription factor involved in the regulation of pluripotency during embryonic development. It can be detected
in both pluripotent cells and other early
germ cells. This study examines the expression of OCT4 in both dysgerminoma and nondysgerminomatous
neoplasms involving the ovary. Formalin-fixed,
paraffin-embedded cell blocks of 33 cases of dysgerminoma
including 2 cases of gonadoblastoma associated
with dysgerminoma and 3 cases of metastatic
dysgerminoma, and 111 cases of nondysgerminomatous
neoplasms involving the ovary were stained
using the antibody against OCT4. All cases of dysgerminomas
and gonadoblastomas were positive for OCT4
with strong nuclear staining. More than 90% of dysgerminoma
cells in each case showed diffuse strong nuclear staining. In addition,
3 metastatic dysgerminomas also showed
uniform strong nuclear staining. All nondysgerminomatous
tumors (mature teratoma, 14; yolk sac tumor,
4; Sertoli-Leydig cell tumor, 15; granulosa
cell tumor, 22; Brenner tumor, 3; carcinoid
tumor, 4; struma ovarii,
2; fibroma, 5; thecoma, 1; serous adenocarcinoma, 5; endometrioid
adenocarcinoma, 4; small cell carcinoma, 6; stromal sarcoma, 1; malignant lymphoma, 6; metastatic malignant melanoma, 1; metastatic
carcinoid, 2; metastatic
small cell carcinoma, 1; and metastatic lobular
carcinoma of the breast, 1) were negative for OCT4, except for some
cases of clear cell adenocarcinoma of the
ovary. Four of 14 clear cell adenocarcinomas
showed focal positive nuclear immunoreactivity
for OCT4. OCT4 is a sensitive and relatively specific biomarker for
the detection of dysgerminoma. It may also be useful in the diagnosis of gonadoblastoma, which contains similar cells and may be associated
with dysgerminoma. OCT4 may aid in the detection
of small foci of metastatic dygerminoma in extraovarian sites
and may also help distinguish dysgerminoma
from other primary and metastatic tumors of
the ovary.
American Journal
of Surgical Pathology. 28(10): 1341-1346, October 2004
The Value of Immunohistochemistry in Atypical Cutaneous
Fibrous Histiocytoma
Wilk M, Zelger
BG, Nilles M, Zelger
B.
Atypical cutaneous fibrous histiocytoma(ACFH)is a rare
variant of dermatofibroma/fibrous histiocytoma
characterized by striking atypia, thus resembling
atypical fibroxanthoma. Authors studied 9 examples of
ACFH histopathologically and immunohistochemically
to investigate the nature of these atypical cells.Histology revealed ill-defined skin nodules, which
were polypoid in 6 cases. A minority of mononuclear
and giant cells (< 5%) revealed striking pleomorphism
and showed large nuclei with prominent nucleoli. Immunohistologically,
the atypical cells expressed vimentin, but were negative
for S-100 protein, the keratin marker MNF116, alpha smooth muscle actin, CD34, factor XIIIa, and monocyte/macrophage markers Ki-M1p, KP1 (CD68), and MAC387.
Positivity for MiB1 was very modest (< 1%) and
limited to small- and medium-sized, inconspicuous cells. Multinucleate giant
cells proved to be heterogenous, on one hand cells
with differentiation toward macrophages with positivity
for Ki-M1p and KP1, on the other toward fibroblasts positive for vimentin only. These immuno-histochemical
results for differentiation markers in atypical cutaneous
fibrous histiocytoma are similar to our previous
findings and data in atypical fibroxanthoma; MiB1
helps to separate these entities from each other as the latter shows a very
high proportion of proliferative atypical cells
corresponding to the numerous mitoses seen in routine sections.
Am
J Dermatopathol. 2004 Oct; 26(5): 367-371.
CYTOPATHOLOGY
Psammoma Bodies
in Cervicovaginal Smears: Significance and
Practical Implications for Diagnostic Cytopathology
Fadare, Oluwole MD; Chacho, Mary S MD; Parkash,
Vinita MD
The traditional association of psammoma bodies with
some malignancies of the gynecologic tract raises potentially significant
management difficulties when such bodies are identified on routine cervicovaginal smears. This review summarizes the reported
cases of psammoma bodies identified on cervicovaginal smears in the world literature (a total of
140 cases, 113 (81%) of which had sufficient clinicopathologic
information). Authors conclusions are as follows: (1) The
finding of psammoma bodies in this setting is
distinctly unusual with an incidence of less than 0.001% on consecutively
screened smears. (2) On consecutively screened smears, patients with psammoma bodies have an associated malignancy or ovarian
borderline tumor 0-22.7% of the time, depending on the series; this figure
climbs to 38% when all the case reports and small series in the literature are
included. (3) The most reliable predictor of a malignancy in these patients is
the finding of cells on the smear that by themselves are diagnostic of
malignancy on cytologic grounds. (4) Other factors
that, on a purely statistical basis, appear to increase the likelihood of a
synchronous or metachronous malignancy or borderline
tumor include an older age at diagnosis and/or clinical presentations such as
postmenopausal bleeding. (5) When 1 or more psammoma
bodies are identified on a cervicovaginal smear, this
finding should not be ignored and should generate some clinical investigation
to identify its source.
Advances
in Anatomic Pathology.
11(5): 250-261, September 2004.
MICROBIOLOGY
Bacteria Tied to Chron's Disease
Research published in The Lancet gives evidence that
implicates Mycobacterium avium paratuberculosis (MAP) infection as a cause of Crohn's disease. The study used a novel approach to investigate
this link between bacteria and the disease.
Researchers said that viable MAP was detected in half of
the patients with Crohn's disease, but in none of the
control subjects lacking inflammatory bowel disease. This finding alone does
not prove that MAP is a causative agent; however, it suggest
that larger-scale studies will follow.
Researchers tested for MAP in blood samples from 28
patients with Crohn's disease, 9 with ulcerative
colitis, and 15 without inflammatory bowel disease. Fourteen patients with Crohn's disease had specimens that grew viable MAP in
culture. Only 2 ulcerative colitis patients cultured positive for MAP, and no
control subjects cultured MAP.
In a related editorial in The Lancet, Dr. Warwick S.
Selby, from the University of Sydney in Australia, comments, "whatever one's view, MAP
cannot continue to be ignored in Crohn's disease. Funding bodies and laboratory and clinical
researchers must clarify with some urgency, once and for all, whether this
organism is important in Crohn's disease or is merely
a curious bystander."
American
Journal of Clinical Pathology, Sept. 19 2004
Unrecognised tuberculosis
in HIV-infected patients: sputum culture is a useful tool
Swaminathan
S, Paramasivan CN, Kumar SR, Mohan V, Venkatesan
P.
Diagnosis of tuberculosis is challenging, especially in human immunodeficiency
virus (HIV) positive persons who may have atypical clinical and radiographic
features. We report the isolation of Mycobacterium tuberculosis from
sputum samples of 10 (4%) HIV-positive persons who
were asymptomatic with normal chest radiographs and negative sputum
smears for acid-fast bacilli. Six of them had strongly positive
tuberculin reactions while four were severely immunosuppressed.
Authors observation highlights the utility
of routine sputum culture in the diagnosis of tuberculosis in high-risk
individuals.
Int J Tuberc Lung Dis.
2004 Jul;8(7): 896-8.
Enhanced Culture
Detection of Kingella kingae,
a Pathogen of Increasing Clinical Importance in Pediatrics
Gene
A, Garcia-Garcia JJ, Sala P, Sierra M, Huguet R.
Osteoarticular infection and occult bacteremia are the 2 invasive infectious pathologies most
frequently associated in childhood with Kingella
kingae. Authors report a series of 11 patients in whom osteomyelitis predominates over septic arthritis, which is
the reverse of other series, probably as a consequence of inoculation
of samples during surgery on agar media, used in combination with or
as an alternative to inoculation into blood culture bottles. Although
K. kingae infections usually follow a benign clinical course,
authors noted 2 patients with mild orthopedic sequelae.
Pediatr Infect Dis J. 2004 Sep; 23(9):
886-888.